loadpatents
name:-0.06673002243042
name:-0.054044961929321
name:-0.0075581073760986
Cleland; Jeffrey L. Patent Filings

Cleland; Jeffrey L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cleland; Jeffrey L..The latest application filed is for "aggregated microparticles".

Company Profile
5.50.57
  • Cleland; Jeffrey L. - San Carlos CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aggregating microparticles for medical therapy
Grant 11,331,276 - Yu , et al. May 17, 2
2022-05-17
Extended release microparticles and suspensions thereof for medical therapy
Grant 11,160,870 - Yang , et al. November 2, 2
2021-11-02
Aggregated Microparticles
App 20210275456 - Yang; Ming ;   et al.
2021-09-09
Compounds And Compositions For Ocular Delivery
App 20210214374 - Bauman; John G. ;   et al.
2021-07-15
Extended recombinant polypeptides and compositions comprising same
Grant 10,961,287 - Schellenberger , et al. March 30, 2
2021-03-30
Drugs To Treat Ocular Disorders
App 20210040111 - Yang; Ming ;   et al.
2021-02-11
Drugs And Compositions For Ocular Delivery
App 20200308162 - Cleland; Jeffrey L. ;   et al.
2020-10-01
Extended Release Microparticles And Suspensions Thereof For Medical Therapy
App 20200230246 - Yang; Ming ;   et al.
2020-07-23
Drugs And Compositions For The Treatment Of Ocular Disorders
App 20200031783 - Yang; Ming ;   et al.
2020-01-30
Aggregating Microparticles For Medical Therapy
App 20200000735 - Yu; Yun ;   et al.
2020-01-02
Aggregating Microparticles For Medical Therapy
App 20200000734 - Yu; Yun ;   et al.
2020-01-02
Compounds and compositions for the treatment of ocular disorders
Grant 10,485,876 - Cleland , et al. Nov
2019-11-26
Aggregating microparticles for medical therapy
Grant 10,441,548 - Yu , et al. Oc
2019-10-15
Compounds And Compositions For The Treatment Of Ocular Disorders
App 20190060474 - Cleland; Jeffrey L. ;   et al.
2019-02-28
Compounds and compositions for the treatment of ocular disorders
Grant 10,159,747 - Cleland , et al. Dec
2018-12-25
Extended Release Microparticles And Suspensions Thereof For Medical Therapy
App 20180326078 - Yang; Ming ;   et al.
2018-11-15
Compounds and compositions for the treatment of ocular disorders
Grant 10,117,950 - Cleland , et al. November 6, 2
2018-11-06
Compounds and compositions for the treatment of ocular disorders
Grant 10,111,964 - Cleland , et al. October 30, 2
2018-10-30
Compounds and compositions for the treatment of ocular disorders
Grant 10,098,965 - Cleland , et al. October 16, 2
2018-10-16
Extended Recombinant Polypeptides And Compositions Comprising Same
App 20180244736 - Schellenberger; Volker ;   et al.
2018-08-30
Glucose-regulating polypeptides and methods of making and using same
Grant 10,000,543 - Schellenberger , et al. June 19, 2
2018-06-19
Growth Hormone Polypeptides And Methods Of Making And Using Same
App 20180161443 - Schellenberger; Volker ;   et al.
2018-06-14
Compounds and compositions for the treatment of ocular disorders
Grant 9,956,302 - Cleland , et al. May 1, 2
2018-05-01
Compounds And Compositions For The Treatment Of Ocular Disorders
App 20180104350 - Cleland; Jeffrey L. ;   et al.
2018-04-19
Extended recombinant polypeptides and compositions comprising same
Grant 9,926,351 - Schellenberger , et al. March 27, 2
2018-03-27
Compounds And Compositions For The Treatment Of Ocular Disorders
App 20180064823 - Cleland; Jeffrey L. ;   et al.
2018-03-08
Treatment With Human Growth Hormone Analogues
App 20180051063 - Cleland; Jeffrey L. ;   et al.
2018-02-22
Compounds And Compositions For The Treatment Of Ocular Disorders
App 20180036416 - Cleland; Jeffrey L. ;   et al.
2018-02-08
Compounds And Compositions For The Treatment Of Ocular Disorders
App 20180028673 - Cleland; Jeffrey L. ;   et al.
2018-02-01
Growth hormone polypeptides and methods of making and using same
Grant 9,849,188 - Schellenberger , et al. December 26, 2
2017-12-26
Compounds and compositions for the treatment of ocular disorders
Grant 9,808,531 - Cleland , et al. November 7, 2
2017-11-07
Glucose-regulating Polypeptides And Methods Of Making And Using Same
App 20170158748 - Schellenberger; Volker ;   et al.
2017-06-08
Aggregating Microparticles For Medical Therapy
App 20170135960 - Yu; Yun ;   et al.
2017-05-18
Growth Hormone Polypeptides And Methods Of Making And Using Same
App 20170095567 - Schellenberger; Volker ;   et al.
2017-04-06
Compounds And Compositions for the Treatment of Ocular Disorders
App 20170080092 - Cleland; Jeffrey L. ;   et al.
2017-03-23
Extended Recombinant Polypeptides And Compositions Comprising Same
App 20170037088 - Schellenberger; Volker ;   et al.
2017-02-09
Glucose-regulating polypeptides and methods of making and using same
Grant 9,540,430 - Schellenberger , et al. January 10, 2
2017-01-10
Extended recombinant polypeptides and compositions comprising same
Grant 9,371,369 - Schellenberger , et al. June 21, 2
2016-06-21
Treatment Of Pediatric Growth Hormone Deficiency With Human Growth Hormone Analogues
App 20160158321 - CLELAND; Jeffrey L. ;   et al.
2016-06-09
Protein formulation
Grant 9,283,273 - Andya , et al. March 15, 2
2016-03-15
Growth hormone polypeptides and methods of making and using same
Grant 9,168,312 - Schellenberger , et al. October 27, 2
2015-10-27
Glucose-regulating Polypeptides And Methods Of Making And Using Same
App 20150274800 - Schellenberger; Volker ;   et al.
2015-10-01
Glucose-regulating polypeptides and methods of making and using same
Grant 8,957,021 - Schellenberger , et al. February 17, 2
2015-02-17
Growth Hormone Polypeptides And Methods Of Making And Using Same
App 20140371136 - Schellenberger; Volker ;   et al.
2014-12-18
Recombinant production of vascular endothelial growth factor
Grant 8,906,648 - Butler , et al. December 9, 2
2014-12-09
Extended Recombinant Polypeptides And Compositions Comprising Same
App 20140301974 - Schellenberger; Volker ;   et al.
2014-10-09
Treatment With Human Growth Hormone Analogues
App 20140162949 - Cleland; Jeffrey L. ;   et al.
2014-06-12
Growth hormone polypeptides and methods of making and using same
Grant 8,703,717 - Schellenberger , et al. April 22, 2
2014-04-22
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
Grant 8,680,050 - Schellenberger , et al. March 25, 2
2014-03-25
Extended recombinant polypeptides and compositions comprising same
Grant 8,673,860 - Schellenberger , et al. March 18, 2
2014-03-18
Protein Formulation
App 20130224185 - Andya; James ;   et al.
2013-08-29
Recombinant Production of Heparin Binding Proteins
App 20130217867 - Butler; Michelle D. ;   et al.
2013-08-22
Bioerodible polymers for injection
Grant 8,501,216 - Cleland , et al. August 6, 2
2013-08-06
High Pressure Treatment of Aggregated Interferons
App 20130058895 - Cleland; Jeffrey L. ;   et al.
2013-03-07
High pressure treatment of aggregated interferons
Grant 8,273,561 - Cleland , et al. September 25, 2
2012-09-25
Bifunctional Polypeptide Compositions And Methods For Treatment Of Metabolic And Cardiovascular Diseases
App 20110312881 - Silverman; Joshua ;   et al.
2011-12-22
Sustained release formulation
Grant 8,067,020 - Okumu , et al. November 29, 2
2011-11-29
Protein Formulation
App 20110236383 - Andya; James ;   et al.
2011-09-29
Erodible Polymers For Injection
App 20110152190 - CLELAND; Jeffrey L. ;   et al.
2011-06-23
Injection Vehicle For Polymer-based Formulations
App 20100330184 - Cleland; Jeffrey L. ;   et al.
2010-12-30
Erodible polymers for injection
Grant 7,824,700 - Cleland , et al. November 2, 2
2010-11-02
Recombinant Production of Heparin Binding Proteins
App 20100261888 - Butler; Michelle D. ;   et al.
2010-10-14
Extended Recombinant Polypeptides And Compositions Comprising Same
App 20100239554 - Schellenberger; Volker ;   et al.
2010-09-23
Protein Formulation
App 20100158899 - Andya; James ;   et al.
2010-06-24
Protein formulation
Grant 7,682,609 - Andya , et al. March 23, 2
2010-03-23
Injection vehicle for polymer-based formulations
Grant 7,651,703 - Cleland , et al. January 26, 2
2010-01-26
Injection vehicle for polymer-based formulations
Grant 7,582,311 - Cleland , et al. September 1, 2
2009-09-01
High pressure treatment of aggregated interferons
App 20090208453 - Cleland; Jeffrey L. ;   et al.
2009-08-20
Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds
App 20090163453 - Curd; John G. ;   et al.
2009-06-25
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
App 20090069276 - Curd; John G. ;   et al.
2009-03-12
Sustained Release Formulation
App 20080090754 - Okumu; Franklin ;   et al.
2008-04-17
Sustained release formulation
Grant 7,318,931 - Okumu , et al. January 15, 2
2008-01-15
Treatment of hyperproliferative diseases with anthraquinones
App 20070117784 - Cleland; Jeffrey L. ;   et al.
2007-05-24
Injection Vehicle For Polymer-based Formulations
App 20070098736 - Cleland; Jeffrey L. ;   et al.
2007-05-03
Controlled release microencapsulated NGF formulation
Grant 7,163,701 - Cleland , et al. January 16, 2
2007-01-16
Protein formulation
App 20060275306 - Andya; James ;   et al.
2006-12-07
Pharmaceutical compositions comprising active vitamin D compounds
App 20060189586 - Cleland; Jeffrey L.
2006-08-24
Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents
App 20060178351 - Curd; John G. ;   et al.
2006-08-10
Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
App 20060177374 - Curd; John G. ;   et al.
2006-08-10
Treatment of lung cancer with active vitamin D compounds in combination with other treatments
App 20060172014 - Curd; John G. ;   et al.
2006-08-03
Protein formulation
Grant 7,060,268 - Andya , et al. June 13, 2
2006-06-13
Compositions for microencapsulation of antigens for use as vaccines
Grant 6,913,767 - Cleland , et al. July 5, 2
2005-07-05
Protein formulation
Grant 6,821,515 - Cleland , et al. November 23, 2
2004-11-23
Targeted therapeutic lipid constructs
App 20040067196 - Brunke, Karen J. ;   et al.
2004-04-08
Protein formulation
Grant 6,685,940 - Andya , et al. February 3, 2
2004-02-03
Controlled release microencapsulated NGF formulation
Grant 6,663,899 - Cleland , et al. December 16, 2
2003-12-16
Protein formulation
App 20030202972 - Andya, James ;   et al.
2003-10-30
Controlled release microencapsulated NGF formulation
App 20030203040 - Cleland, Jeffrey L. ;   et al.
2003-10-30
Sustained release formulation
App 20030045454 - Okumu, Franklin ;   et al.
2003-03-06
Erodible polymers for injection
App 20020173552 - Cleland, Jeffrey L. ;   et al.
2002-11-21
Controlled Release Microencapsulated Ngf Formulation
App 20020004481 - CLELAND, JEFFREY L. ;   et al.
2002-01-10
Protein formulation
App 20010014326 - Andya, James ;   et al.
2001-08-16
Protein formulation
Grant 6,267,958 - Andya , et al. July 31, 2
2001-07-31
Controlled release microencapsulated NGF formulation
Grant 6,113,947 - Cleland , et al. September 5, 2
2000-09-05
Method for drying microspheres
Grant 6,080,429 - Cleland , et al. June 27, 2
2000-06-27
Excipient stabilization of polypeptides treated with organic solvents
Grant 5,804,557 - Cleland , et al. September 8, 1
1998-09-08
Excipient stabilization of polypeptides treated with organic solvents
Grant 5,753,219 - Cleland , et al. May 19, 1
1998-05-19
Methods and compositions for microencapsulation of adjuvants
Grant 5,643,605 - Cleland , et al. July 1, 1
1997-07-01
Excipient stabilization of polypeptides treated with organic solvents
Grant 5,589,167 - Cleland , et al. December 31, 1
1996-12-31
Company Registrations
SEC0001601948Cleland Jeffrey L

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed